| Julie Keeton, PHARMD | |
|
721 W Kansas Ave Ste 101, Greensburg, KS 67054-1633 | |
| (620) 723-3112 | |
| (620) 723-3421 |
| Full Name | Julie Keeton |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 721 W Kansas Ave Ste 101, Greensburg, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407257512 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 1-15102 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Julie Keeton, PHARMD 721 W Kansas Ave Ste 101, Greensburg, KS 67054-1633 Ph: (620) 723-3112 | Julie Keeton, PHARMD 721 W Kansas Ave Ste 101, Greensburg, KS 67054-1633 Ph: (620) 723-3112 |
News Archive
Astronauts on board Space Shuttle Discovery (STS-131) activated an experiment this morning as part of the ninth scientific payload for Astrogenetix, an Austin, Texas-based commercial biotech company. Astrogenetix is conducting the International Space Station National Laboratory Pathfinder Vaccine (NLP-V) missions to take advantage of the unique conditions of microgravity to uncover changes in bacteria that can be targeted to create new vaccines and therapeutics.
The team of researchers from the Universities of Bristol, Queensland, Oxford, Texas and Toronto, used a technique called genome-wide association where millions of genetic markers are measured in thousands of people that have the disease and thousands of healthy individuals.
Researchers from the Hospital Clinic of Barcelona (Spain) have reviewed ten years' worth of scientific studies on mitochondrial toxicity in pregnant women. Exposure to toxic agents such as viruses, certain drugs, pesticides, alcohol and tobacco cause mitochondrial diseases about which very little is known, and which are transmitted from the mother to the foetus.
Shire plc, the global specialty biopharmaceutical company, announces that Health Canada has approved VPRIV (velaglucerase alfa), an enzyme replacement therapy (ERT) for long-term use in pediatric and adult type 1 Gaucher disease.
› Verified 9 days ago
Micah Cole Kendall, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 112 S Main St, Greensburg, KS 67054 Phone: 620-723-3112 Fax: 620-723-3421 |